# Trade Mark Journal No.2026/011 13 March 2026

## WO0000001904733 (5)

Office of origin: United States of America

Date of International Registration:16 January 2026
Date of designation in the UK: 16 January 2026

The mark consists of the wording "KYGEVVI" in stylized font with the lettering appearing in a turquoise font.

The mark contains the colour turquoise.

The mark consists of the wording "KYGEVVI" in stylized font with the lettering appearing in a turquoise font.

International priority date claimed: 27 August 2025 (United States of America) (99359933)

Class 5
  Pharmaceutical preparations for the treatment of tk2 gene diseases and disorders, mitochondrial depletion syndrome disease and disorders, and enzyme deficiency diseases and disorders.

UCB Biosciences Inc.

Representative: Kumiko Ide Wenderoth, Lind & Ponack, LLP, 1025 Connecticut Avenue NW, Suite 500, Washington DC 20036, UNITED STATES OF AMERICA